S&P 500
(0.29%) 5 114.96 points
Dow Jones
(0.31%) 38 357 points
Nasdaq
(0.34%) 15 982 points
Oil
(-0.91%) $83.09
Gas
(5.77%) $2.03
Gold
(0.36%) $2 355.70
Silver
(0.44%) $27.66
Platinum
(4.01%) $959.10
USD/EUR
(-0.22%) $0.933
USD/NOK
(-0.38%) $10.98
USD/GBP
(-0.54%) $0.796
USD/RUB
(1.69%) $93.43

リアルタイムの更新: STAAR Surgical Co [STAA]

取引所: NASDAQ セクター: Healthcare 産業: Medical Instruments & Supplies
BUY
83.33%
return 7.66%
SELL
33.33%
return 8.41%
最終更新日時30 4月 2024 @ 01:34

1.70% $ 47.76

買う 107752 min ago

@ $29.87

発行日: 15 2月 2024 @ 05:49


リターン: 59.89%


前回のシグナル: 2月 14 - 23:30


前回のシグナル: 売る


リターン: -0.71 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:34):
Profile picture for STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye...

Stats
本日の出来高 89 793.00
平均出来高 719 372
時価総額 2.35B
EPS $0 ( 2024-02-26 )
次の収益日 ( $0.0400 ) 2024-06-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 111.07
ATR14 $0.0670 (0.14%)
Insider Trading
Date Person Action Amount type
2024-03-14 Weisner Aimee S Buy 1 750 Common Stock
2024-03-12 Frinzi Thomas G Buy 74 389 Restricted Stock Units
2024-03-12 Frinzi Thomas G Buy 66 627 Common Stock Options
2024-03-12 Foust Warren Buy 24 525 Restricted Stock Units
2024-03-12 Foust Warren Buy 21 966 Common Stock Options
INSIDER POWER
98.83
Last 95 transactions
Buy: 2 389 846 | Sell: 13 779

ボリューム 相関

長: -0.36 (neutral)
短: 0.03 (neutral)
Signal:(55.861) Neutral

STAAR Surgical Co 相関

10 最も正の相関
GAINL0.905
ISNS0.847
TDAC0.82
MAT0.815
ASTE0.813
10 最も負の相関
BOCH-0.879
SHSP-0.866

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

STAAR Surgical Co 相関 - 通貨/商品

The country flag 0.02
( neutral )
The country flag -0.04
( neutral )
The country flag 0.00
( neutral )
The country flag 0.30
( neutral )
The country flag -0.76
( moderate negative )
The country flag -0.40
( neutral )

STAAR Surgical Co 財務諸表

Annual 2023
収益: $322.42M
総利益: $252.65M (78.36 %)
EPS: $0.440
FY 2023
収益: $322.42M
総利益: $252.65M (78.36 %)
EPS: $0.440
FY 2022
収益: $284.39M
総利益: $223.38M (78.55 %)
EPS: $0.830
FY 2021
収益: $230.47M
総利益: $178.64M (77.51 %)
EPS: $0.520

Financial Reports:

No articles found.

STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。